Screener
UroGen Pharma URGN Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$14.35M+71.3% | -$23.57M+46.2% | -$26.36M+29.7% | -$33.35M-40.9% | -$49.94M-49.5% | ||
| $100K0.0% | $75K+4.2% | $75K+10.3% | $100K0.0% | $100K0.0% | ||
| $5.33M+95.1% | $4.63M+50.8% | $3.13M-5.2% | $3.03M-13.2% | $2.73M-23.2% | ||
| -$33.01M+17.1% | -$45.32M-7.8% | -$38.33M-181% | -$42.27M-52.8% | -$39.83M-67.7% | ||
| $60K-57.4% | $54K+22.7% | $17K-85.2% | $87K-9.4% | $141K+67.9% | ||
| —— | -$20.69M+20.3% | $27.72M— | $31.4M+129% | $28.41M+137% | ||
| —— | $65.35M— | $0-100% | $0-100% | $0-100% | ||
| $500K+68.9% | $65.2M+191,676% | $31.32M+44,007% | $8.27M-79.1% | $296K-99.7% | ||
| -$30.83M-177% | -$800K+98.8% | —— | -$2.6M— | -$11.12M-113% | ||
| -$33.07M+17.3% | -$45.37M-7.8% | -$38.34M-179% | -$42.36M-52.6% | -$39.97M-67.7% |
FAQ
- How much cash does UroGen Pharma generate?
- UroGen Pharma (URGN) generated -$158.9M in operating cash flow over the trailing twelve months.
- What is UroGen Pharma's free cash flow?
- After $218.0K of capital expenditures, UroGen Pharma's free cash flow was -$159.1M over the trailing twelve months, down 28.8% year over year.
- Where does UroGen Pharma's cash flow data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
